[HONG KONG, May 22, 2023] Recently, the third Asia Summit on Global Healthcare co-organized by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC) was successfully held in Hong Kong. The ASGH attracted over 2,500 participants from 40 countries and regions. The Medical Fair welcomed over 10,000 visitors from 56 countries and regions. Mr. John Lee, the Chief Executive of HKSAR attended the forum and delivered a speech. Ms. Yu Yanhong, the Member of Leading Party Member’s Group of the National Health Commission, and Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, delivered speeches. Great Bay Bio team attended the event and presented the AI-enabled Cell Engineering Platform, and had a great experience and discussed the development prospects and business opportunities of global public health, medical technology and medical investment with health officials, international medical experts and investors from all over the world.
The 3rd Asia Summit on Global Healthcare in Hong Kong
Mr. Kingsley Leung, chairman and co-founder of Great Bay Bio, interviewed by HKET
With the theme of "Reimagining the Future of Healthcare", the forum attracted the participation of government officials in charge of healthcare, international scientific research and medical experts, investors, and relevant professional representatives from all over the world. “Hong Kong will take advantage of the growing connectivity within the Guangdong-Hong Kong-Macao Greater Bay Area and join hands with R&D and innovation institutions, businesses, and professionals to build a more resilient and sustainable global health system”, the Chief Executive of HKSAR, Mr. John Lee said.
Speech by Mr. John Lee, the Chief Executive of HKSAR
Speech by Yu Yanhong, the Member of Leading Party Member’s Group of the National Health Commission
Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, delivered a speech
Great Bay Bio team was invited to attend the summit. The Chief Commercial Officer Dr. Kane Qi gave a speech on the theme of "AI-enabled Cell Line Engineering Platform" and shared the advantages of the AI-enabled cell engineering platform to enable bioprocess development, making Global Bioprocessing Simpler and More Efficient. The platform is widely used in the rapid development of recombinant proteins, mAbs, BsAbs, polyclonal antibodies, ADC drugs and other biological drugs, and continues to help vaccines, in vitro diagnostics, gene therapy, industrial enzyme preparations, cultured meat, synthetic biology and other fields.
Great Bay Bio team attended HK ASGH 2023
About ASGH
Bringing together all the stakeholders - from healthcare experts to renowned academia and influential business leaders, together with key industry players, innovative start-ups, investors, and policymakers from around the world to exchange insights, explore opportunities and collaborate on the diverse and dynamic healthcare sector.
